These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 203123)

  • 41. [Classification of hyperlipoproteinemias].
    Zabel R
    Dermatol Monatsschr; 1974 Feb; 160(2):134-50. PubMed ID: 4369507
    [No Abstract]   [Full Text] [Related]  

  • 42. [Blood lipids and lipoproteins in the age aspect and their role in the development of arteriosclerosis].
    Klimov AN
    Vestn Akad Med Nauk SSSR; 1980; (3):45-9. PubMed ID: 7395328
    [No Abstract]   [Full Text] [Related]  

  • 43. Evaluation of rapid screening methods for the detection of abnormal lipid states related to atherosclerosis.
    Boyle E; Dash HH; Owen D; Yarmosh D
    Ann Clin Lab Sci (1971); 1972; 2(5):393-403. PubMed ID: 4343280
    [No Abstract]   [Full Text] [Related]  

  • 44. Advances in lipoprotein research: biochemical and clinical aspects.
    Schettler G; Seidel D; Greten H
    Med J Aust; 1973 May; 1(19):942-6. PubMed ID: 4351788
    [No Abstract]   [Full Text] [Related]  

  • 45. Hyperlipoproteinemia type IV and pre-beta-lipoprotein. Some new aspects of its physiology, pathogenesis and diagnosis.
    Wille LE
    J Oslo City Hosp; 1972; 22(11):169-84. PubMed ID: 4344735
    [No Abstract]   [Full Text] [Related]  

  • 46. [Concepts and classification of hyperlipidemia and hyperlipoproteinemia with special reference to the classifications according to Frederickson and WHO].
    Naito C
    Nihon Rinsho; 1975 Nov; 33(11):3139-46. PubMed ID: 173901
    [No Abstract]   [Full Text] [Related]  

  • 47. Clinical evaluation of cinnarizine in hyperlipaemic patients.
    Saba P; Galeone F; Salvadorini F; Guarguaglini M; Houben JL
    G Clin Med; 1974 Aug; 55(8):586-99. PubMed ID: 4377134
    [No Abstract]   [Full Text] [Related]  

  • 48. [Effect of bezafibrate on disorders of lipid metabolism].
    Stryjek-Kamińska D; Ilińska-Debniak K; Bartosiewicz W; Szczepanik Z
    Pol Tyg Lek; 1983 Dec; 38(50):1567-71. PubMed ID: 6379618
    [No Abstract]   [Full Text] [Related]  

  • 49. A physician's guide to hyperlipidemia.
    Fredrickson DS
    Mod Concepts Cardiovasc Dis; 1972 Jul; 41(7):31-6. PubMed ID: 4343098
    [No Abstract]   [Full Text] [Related]  

  • 50. [Hyperlipemia and lipoproteinogram].
    Fruchart JC; Sezille G; Jaillard J; Decoopman E; Desreumeaux C
    Lille Med; 1974 Feb; 19(2):84-6. PubMed ID: 4368153
    [No Abstract]   [Full Text] [Related]  

  • 51. [Classification of hyperlipoproteinemia. II. Distribution principle of hyperlipoproteinemias according to Fredrickson et al. correlated with clinical dermatological possibilities].
    Zabel R
    Dermatol Monatsschr; 1973 Dec; 159(12):1137-43. PubMed ID: 4366868
    [No Abstract]   [Full Text] [Related]  

  • 52. [Abnormalities of apolipoprotein E (type III hyperlipoproteinemia)].
    Yamamura T
    Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):46-9. PubMed ID: 9645005
    [No Abstract]   [Full Text] [Related]  

  • 53. [Differential diagnosis of hyperlipidemias and hypolipidemias in endocrinologic diseases].
    Szczeklik A
    Przegl Lek; 1974; 31(0):suppl:79-82. PubMed ID: 4369537
    [No Abstract]   [Full Text] [Related]  

  • 54. Hyperlipidemia.
    Sloan RW
    Am Fam Physician; 1983 Sep; 28(3):171-82. PubMed ID: 6613796
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Drug therapy of hyperlipidemias].
    Wolfram G
    Wien Med Wochenschr; 1981; 131(13-14):333-8. PubMed ID: 7281700
    [No Abstract]   [Full Text] [Related]  

  • 56. [Hyperlipoproteinemia--problems of diagnosis and treatment. Report of the Working Group of the Polish Cardiology Society].
    Michajlik A; Ciświcka-Sznajderman M; Sznajd J; Szostak W
    Kardiol Pol; 1982; 25(12):1061-8. PubMed ID: 7169735
    [No Abstract]   [Full Text] [Related]  

  • 57. Macromolecular dispersion of human plasma low-density lipoproteins in hyperlipoproteinemia.
    Hammond MG; Mengel MC; Warmke GL; Fisher WR
    Metabolism; 1977 Nov; 26(11):1231-42. PubMed ID: 198626
    [No Abstract]   [Full Text] [Related]  

  • 58. Screening for hyperlipidemia in childhood.
    Chase HP; O'Quin RJ; O'Brien D
    JAMA; 1974 Dec; 230(11):1535-7. PubMed ID: 4372417
    [No Abstract]   [Full Text] [Related]  

  • 59. [Proceedings: Reciprocal fluctuations of lipoproteins in fasting therapy of hyperlipoproteinemia].
    Schellenberg B; Schlierf G; Oster P
    MMW Munch Med Wochenschr; 1975 May; 117(20):844. PubMed ID: 166301
    [No Abstract]   [Full Text] [Related]  

  • 60. Type IV and IIb hyperlipoproteinemia and the HLA system.
    Raffoux C; Pointel JP; Sauvanet JP; Drouin P; Janot C; Streiff F; Debry G
    Tissue Antigens; 1978 Sep; 12(3):212-4. PubMed ID: 83019
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.